The current stock price of NVOS is 0.15 USD. In the past month the price decreased by -39.27%. In the past year, price decreased by -90.74%.
ChartMill assigns a fundamental rating of 1 / 10 to NVOS. NVOS may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months NVOS reported a non-GAAP Earnings per Share(EPS) of -1.38. The EPS increased by 84.52% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -68.87% | ||
| ROE | -244.36% | ||
| Debt/Equity | 0.16 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.54 | 95.512B | ||
| CI | THE CIGNA GROUP | 9.08 | 72.582B | ||
| LH | LABCORP HOLDINGS INC | 15.44 | 22.894B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 93.98 | 22.748B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.33 | 21.05B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.676B | ||
| DVA | DAVITA INC | 11.28 | 10.029B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 28.06 | 6.723B | ||
| CHE | CHEMED CORP | 17.62 | 6.284B | ||
| HIMS | HIMS & HERS HEALTH INC | 40.15 | 5.555B |
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 127 full-time employees. The company went IPO on 2005-07-12. The firm owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The firm operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.
NOVO INTEGRATED SCIENCES INC
11120 Ne 2Nd Street, Suite 100
Bellevue WASHINGTON 98004 US
CEO: Robert Mattacchione
Employees: 179
Phone: 12066179797
Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 127 full-time employees. The company went IPO on 2005-07-12. The firm owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The firm operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.
The current stock price of NVOS is 0.15 USD. The price decreased by -13.29% in the last trading session.
NVOS does not pay a dividend.
NVOS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
NOVO INTEGRATED SCIENCES INC (NVOS) operates in the Health Care sector and the Health Care Providers & Services industry.
NOVO INTEGRATED SCIENCES INC (NVOS) has a market capitalization of 2.86M USD. This makes NVOS a Nano Cap stock.